GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kobo Biotech Ltd (BOM:531541) » Definitions » Pretax Margin %

Kobo Biotech (BOM:531541) Pretax Margin % : % (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Kobo Biotech Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Kobo Biotech's Pre-Tax Income for the three months ended in Dec. 2023 was ₹-12.31 Mil. Kobo Biotech's Revenue for the three months ended in Dec. 2023 was ₹0.00 Mil. Therefore, Kobo Biotech's pretax margin for the quarter that ended in Dec. 2023 was %.

The historical rank and industry rank for Kobo Biotech's Pretax Margin % or its related term are showing as below:


BOM:531541's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.15
* Ranked among companies with meaningful Pretax Margin % only.

Kobo Biotech Pretax Margin % Historical Data

The historical data trend for Kobo Biotech's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobo Biotech Pretax Margin % Chart

Kobo Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kobo Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Kobo Biotech's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Kobo Biotech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobo Biotech's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kobo Biotech's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Kobo Biotech's Pretax Margin % falls into.



Kobo Biotech Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Kobo Biotech's Pretax Margin for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-55.534/0
= %

Kobo Biotech's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-12.313/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kobo Biotech  (BOM:531541) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Kobo Biotech Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Kobo Biotech's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kobo Biotech (BOM:531541) Business Description

Traded in Other Exchanges
N/A
Address
Saki Vihar Road, Unit 104, HYDE Park, Opp. Ansa Industrial Estate, Andheri (East), Mumbai, MH, IND, 400 072
Kobo Biotech Ltd is a pharmaceutical company. Its business comprises the manufacturing and sale of APIs (Active Pharmaceutical Ingredients) based on fermentation technology and Intermediates to pharmaceutical companies.

Kobo Biotech (BOM:531541) Headlines

No Headlines